» Articles » PMID: 27321373

Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis

Overview
Journal Eur Urol
Specialty Urology
Date 2016 Jun 21
PMID 27321373
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Context: As a novel therapeutic method for erectile dysfunction (ED), low-intensity extracorporeal shock wave treatment (LI-ESWT) has been applied recently in the clinical setting. We feel that a summary of the current literature and a systematic review to evaluate the therapeutic efficacy of LI-ESWT for ED would be helpful for physicians who are interested in using this modality to treat patients with ED.

Objective: A systematic review of the evidence regarding LI-ESWT for patients with ED was undertaken with a meta-analysis to identify the efficacy of the treatment modality.

Evidence Acquisition: A comprehensive search of the PubMed and Embase databases to November 2015 was performed. Studies reporting on patients with ED treated with LI-ESWT were included. The International Index of Erectile Function (IIEF) and the Erection Hardness Score (EHS) were the most commonly used tools to evaluate the therapeutic efficacy of LI-ESWT.

Evidence Synthesis: There were 14 studies including 833 patients from 2005 to 2015. Seven studies were randomized controlled trials (RCTs); however, in these studies, the setup parameters of LI-ESWT and the protocols of treatment were variable. The meta-analysis revealed that LI-ESWT could significantly improve IIEF (mean difference: 2.00; 95% confidence interval [CI], 0.99-3.00; p<0.0001) and EHS (risk difference: 0.16; 95% CI, 0.04-0.29; p=0.01). Therapeutic efficacy could last at least 3 mo. The patients with mild-moderate ED had better therapeutic efficacy after treatment than patients with more severe ED or comorbidities. Energy flux density, number of shock waves per treatment, and duration of LI-ESWT treatment were closely related to clinical outcome, especially regarding IIEF improvement.

Conclusions: The number of studies of LI-ESWT for ED have increased dramatically in recent years. Most of these studies presented encouraging results, regardless of variation in LI-ESWT setup parameters or treatment protocols. These studies suggest that LI-ESWT could significantly improve the IIEF and EHS of ED patients. The publication of robust evidence from additional RCTs and longer-term follow-up would provide more confidence regarding use of LI-ESWT for ED patients.

Patient Summary: We reviewed 14 studies of men who received low-intensity extracorporeal shock wave treatment (LI-ESWT) for erectile dysfunction (ED). There was evidence that these men experienced improvements in their ED following LI-ESWT.

Citing Articles

Shock Wave Therapy in the Treatment of Erection Dysfunction: How to Define Clinical Outcomes? A Comparison Between Penile Doppler Ultrasound and a New Visual Erec-tion Hardness Score (V-EHS) During a Blinded, Sham-Controlled Trial.

Schuh M, Vieiralves R, Favorito L Int Braz J Urol. 2025; 51(2).

PMID: 39913097 PMC: 11884628. DOI: 10.1590/S1677-5538.IBJU.2024.9927.


Nutraceutical and low energy shockwave treatments improved sexual function recovery in a rat pelvic neurovascular injury model.

Crisostomo-Wynne T, Hertz A, Ferrini M, Brand T, Salgar S Sex Med. 2025; 12(6):qfaf001.

PMID: 39845379 PMC: 11750428. DOI: 10.1093/sexmed/qfaf001.


The multifaceted nature of diabetic erectile dysfunction: uncovering the intricate mechanisms and treatment strategies.

Ma J, Chen Y, Si Y, Qian J, Wang C, Jin J Front Endocrinol (Lausanne). 2024; 15:1460033.

PMID: 39583965 PMC: 11581859. DOI: 10.3389/fendo.2024.1460033.


Efficacy of platelet-rich plasma in the treatment of erectile dysfunction: A meta-analysis of controlled and single-arm trials.

Du S, Sun S, Guo F, Liu H PLoS One. 2024; 19(11):e0313074.

PMID: 39541282 PMC: 11563399. DOI: 10.1371/journal.pone.0313074.


Retrospective analysis of the efficacy of low-intensity extracorporeal shock wave therapy on young and middle-aged patients with erectile dysfunction responsive to PDE5Is: reducing the use of PDE5Is.

Yao R, Wang M, Chen Q, Xiao H, Yang P, Ding Y Sex Med. 2024; 12(4):qfae065.

PMID: 39346801 PMC: 11438993. DOI: 10.1093/sexmed/qfae065.